Valute / VSTM
VSTM: Verastem Inc
9.25
USD
0.02
(0.22%)
Il tasso di cambio VSTM ha avuto una variazione del 0.22% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 8.96 e ad un massimo di 9.33.
Segui le dinamiche di Verastem Inc. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
VSTM News
- Mizuho lowers Verastem stock price target to $14 on dilution from financing
- Verastem stock soars after KRAS inhibitor shows strong lung cancer results
- GFH375 shows 68.8% response rate in non-small cell lung cancer study
- Verastem (VSTM) Reports Q2 Loss, Misses Revenue Estimates
- Verastem CEO Paterson sells $7,738 in shares
- Gossamer Bio (GOSS) Reports Q2 Loss, Beats Revenue Estimates
- Earnings Preview: Verastem (VSTM) Q2 Earnings Expected to Decline
- FDA grants fast track designation to Verastem’s pancreatic cancer drug
- Verastem: The Market Is Ignoring The Progress (NASDAQ:VSTM)
- Verastem stock rises after LGSOC treatment data published in medical journal
- Verastem’s cancer drug shows 31% response rate in ovarian cancer trial
- Avutometinib-defactinib combo shows strong results in LGSOC patients
- Verastem: Approval Secured, Moving On To PDAC And KRAS G12D-Related Cancers
- Verastem CEO Paterson sells $1.8k in shares
- Verastem director Gagnon sells $1604 in shares
- Cantor Fitzgerald reiterates overweight rating on Verastem stock
- Meta and Biontech Lead Market Cap Stock Movers on Monday
- Nasdaq Edges Higher; ISM Manufacturing PMI Falls In May - Applied Digital (NASDAQ:APLD), Lyra Therapeutics (NASDAQ:LYRA)
- What's Going On With Verastem Oncology Stock On Monday? - Verastem (NASDAQ:VSTM)
- Verastem reports promising cancer drug trial results
- TD Cowen maintains buy rating on Tempus AI stock after short report
- Verastem Oncology to Present at the Jefferies Global Healthcare Conference
- Verastem stock soars to 52-week high, hits $8.5
- Tempus AI shareholders approve key proposals at annual meeting
Intervallo Giornaliero
8.96
9.33
Intervallo Annuale
2.34
9.43
- Chiusura Precedente
- 9.23
- Apertura
- 9.26
- Bid
- 9.25
- Ask
- 9.55
- Minimo
- 8.96
- Massimo
- 9.33
- Volume
- 2.973 K
- Variazione giornaliera
- 0.22%
- Variazione Mensile
- 53.15%
- Variazione Semestrale
- 63.72%
- Variazione Annuale
- 272.98%
31 agosto, domenica